Research and experimental development on natural sciences and engineering
LYNGSTADAAS BIOMEDICAL CONSULTING AS
Revenue 2024
NOK 794,000
Operating profit
NOK 451,000
Equity
NOK 2.2m
Incorporated
2004
Share capital
NOK 145,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2025 | Trend |
|---|---|---|
| Total operating revenue | 794k | |
| Total operating costs | 343k | |
| Operating profit (EBIT) | 451k | |
| Net financial items | −13k | |
| Profit for the year | 437k |
Balance sheet
| Post | 2025 | Trend |
|---|---|---|
| Total assets | 2.5m | |
| of which current assets | 529k | |
| Equity | 2.2m | |
| Total liabilities | 299k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.